On June 12th, 2008, Invitrogen and Applied Biosystems pronounced plans to merge. The joint business was to be renamed Life Technologies (NASDAQ: LIFE).
Invitrogen offered to get Applied Biosystems for $6.7 billion in cash and stock. AB stockholders would receive $38 per share in cash and stock.
PUBLICATION DATE: June 20, 2012 PRODUCT #: SM209B-PDF-ENG
This is just an excerpt. This case is about STRATEGY & EXECUTION
Related Case Solutions & Analyses:
Eat2Eat.com
The Passion of the Christ (A)
Note on Marketing and the Internet
Postmodern Explained to Managers: Implications for Marketing
Segmentation at Sticks Kebob Shop
The University of Texas: Conference Realignment for College Athletics
Xiamen Honda 4S Shop
Google’s Plans to Enter the WiFi Market
Archibald’s Black & Decker (A): Solving a Classic Marketing Problem in the Power Tools Division
Colgate-Palmolive France (C) (Spanish) Spanish
